Share
Publications
-
27 May 2013 /Prices and reimbursement
Monitor the trends in consumption of drugs for acid-related disorders
The Danish Medicines Agency monitors the consumption of drugs for acid-related disorders (drugs for heartburn, sour eructation and ulcer) in connection with the removal of the reimbursement for a number of these drugs on 15 November 2010.
-
15 April 2011 | Updated 27 May 2013 /Prices and reimbursement
Monitor the trends in consumption of cardiovascular medicines
We monitor the trends in consumption of cardiovascular medicines (blood pressure medicines) in connection with the reimbursement changes for cardiovascular medicines of 13 July 2009 and 15 November 2010.
-
12 November 2012 /Prices and reimbursement
-
02 March 2012 /Prices and reimbursement
Number of applications for individual reimbursement of medicines in 2011
In 2011, the Danish Medicines Agency (now the Danish National Board of Health) reviewed approx. 103,000 applications for single reimbursement (about 7 % more than in 2010), approx. 26,000 applications for reimbursement for the chronically ill (about 30 % less than in 2010), approx. 12,000 applications for reimbursement for the terminally ill (about 3 % more than in 2010) and approx. 2,500 applications for increased reimbursement (about 12 % less than in 2010), cf. table 1.
-
17 February 2005 | Updated 04 November 2011 /Prices and reimbursement
Decreasing consumption of Zyprexa®
The consumption of the antipsychotic medicinal product Zyprexa® decreased during 2004. The decrease in consumption has taken place following EMEA's announcement in March 2004 about a heightened risk of death and brain haemorrhage from treating elderly dementia patients with Zyprexa®.
-
14 June 2011 /Prices and reimbursement
Number of applications for individual reimbursement of medicines in 2010
In 2010, we reached decisions in a total of 144,324 individual reimbursement applications against 138,714 in 2009, corresponding to an increase of 4 %. The figure breaks down to approx. 96,000 applications for single reimbursement (about 3 % fewer than in 2009), approx. 34,000 applications for reimbursement for the chronically ill (about 30 % more than in 2009), approx. 12,000 applications for reimbursement for the terminally ill (about 7 % more than in 2009) and approx. 2,800 applications for increased reimbursement (about 14 % more than in 2009).
-
23 March 2011 /Prices and reimbursement
Annual report of the Reimbursement Committee 2010
In 2010, the Reimbursement Committee reviewed 20 applications for general reimbursement and 1719 applications for individual reimbursement.
-
06 January 2011 /Prices and reimbursement
Elderly people’s consumption of medicinal products
Elderly people's consumption of medicinal products is increasing. Regarding all medicine consumers over the age of 64, the sale measured in DKK and defined daily doses has generally increased from 1999 to 2001.
-
23 April 2010 /Prices and reimbursement
-
31 March 2010 /Prices and reimbursement
-
15 December 2009 /Prices and reimbursement
Considerable increase in consumption of antidiabetic drugs from 1999 to 2008 in Denmark
The number of people in Denmark being diagnosed with diabetes has soared for the past many years, and the same can be said for the sums spent on treatment and medicines for antidiabetics.
-
01 December 2009 /Prices and reimbursement
Sale of dose dispensed medicine in the primary Danish health sector 2004-2008
Dose dispensing was launched in Denmark in 2002, and the use of dose dispensing has increased since then. Dose dispensing is used by all age groups, but the share of users increases with age, and women more frequently use dose dispensed medicine than men.
-
13 July 2009 | Updated 27 August 2009 /Prices and reimbursement
Effective effort against the excessive use of benzodiazepines in Denmark
A long-term use of sleeping medicine and anti-anxiety drugs of the benzodiazepine type should be avoided, as it can lead to addiction, dizziness, memory impairment and concentration difficulties, as well as an increased risk of falling. Throough the years, many political health care initiatives have therefore been launched in order to reduce the consumption of these medicines.
-
17 June 2009 /Prices and reimbursement
Use of prescription weight-loss products from 2003-2007
In recent years, the number of persons treated with prescription-only weight-loss products has increased, however, the total number of persons receiving treatment is lower than before 2002. The weight-loss products are primarily used by women aged between 35-55. In 2007, the number of users was affected by seasonal variations, which are more pronounced if we exclude persons who at the same time receive other medicines associated with overweight.
-
17 June 2009 /Prices and reimbursement
Sale of liberalised OTC medicines from 2001-2007
The liberalisation of over-the-counter products (OTC medicines) may have contributed to an increase in the sale of smoking cessation products in the period from 2001-2007. With regard to the remaining medicinal products, there is nothing to suggest that the sale in general sales outlets has led to increased consumption.
-
28 April 2009 /Prices and reimbursement
-
25 September 2007 /Prices and reimbursement
Dose dispensing in the primary health sector - the first six months of 2007
During the first six months of 2007, 36,962 people had their medicinal products dose dispensed. Elderly women constitute the majority of this group. The consumption of dose dispensed medicinal products accounted for 2.0 percent of the total consumption of medicinal products during the first six months of 2007.
-
30 July 2007 /Prices and reimbursement
The consumption of benzodiazepines and benzodiazepine related drugs
In the 4th quarter 2003, it was decided to launch a range of initiatives with the aim of maintaining and strengthening the trend at the time with an overall decreasing consumption of benzodiazepines and benzodiazepine related drugs. The consumption development over the past five years is shown below.
-
19 July 2007 /Prices and reimbursement
Increase in consumption of urinary antispasmodics
More and more people buy the so-called urinary antispamodics for treatment of overactive bladder. In four years, consumption has increased by 58.6 percent from 19.476 persons in 2001 to 30.899 in 2005. The increased consumption of this type of medicinal products is specifically centred on the more expensive products, which has led to a considerable increase in the sale of these products.
-
19 June 2007 /Prices and reimbursement
Dose dispensing in the primary health sector - the last 6 months of 2006
During the last 6 months of 2006, apporximately 35.000 people had their medicinal products dose dispensed. Elderly women constitute the main part of this group. The consumption of dose dispensed medicinal products amounts to 2.0 per cent of the total consumption of medicinal products during the last 6 months of 2006.
